BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32510186)

  • 1. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
    Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
    J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients lost to follow-up after antiretroviral therapy initiation in rural north-eastern South Africa.
    Ambia J; Kabudula C; Risher K; Xavier Gómez-Olivé F; Rice BD; Etoori D; Reniers G
    Trop Med Int Health; 2019 Jun; 24(6):747-756. PubMed ID: 30920699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
    Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
    Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study.
    Evangeli M; Newell ML; McGrath N
    BMC Public Health; 2016 Apr; 16():358. PubMed ID: 27117271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.
    Chandiwana N; Sawry S; Chersich M; Kachingwe E; Makhathini B; Fairlie L
    Medicine (Baltimore); 2018 Jul; 97(29):e10901. PubMed ID: 30024494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study.
    Nyakato P; Schomaker M; Fatti G; Tanser F; Euvrard J; Sipambo N; Fox MP; Haas AD; Yiannoutsos CT; Davies MA; Cornell M
    J Int AIDS Soc; 2022 Jan; 25(1):e25870. PubMed ID: 35032096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini.
    Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I
    J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.